TRENT-002: A prospective, multicenter, randomized controlled phase II study to evaluate the efficacy and safety of salvage preoperative PD-1 inhibitor combined with chemotherapy neoadjuvant therapy in recurrent laryngeal/hypopharyngeal squamous cell carcinoma (L/HPSCC).
Authors: Xiaohong Chen, Yixin Jing, Yiming Ding
Published: 2025-05-28
DOI:
10.1200/jco.2025.43.16_suppl.tps6119
Source:
Full article
Abstract
TPS6119